344 related articles for article (PubMed ID: 19466978)
1. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.
Chae JJ; Aksentijevich I; Kastner DL
Br J Haematol; 2009 Sep; 146(5):467-78. PubMed ID: 19466978
[TBL] [Abstract][Full Text] [Related]
2. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment.
Chae JJ; Wood G; Richard K; Jaffe H; Colburn NT; Masters SL; Gumucio DL; Shoham NG; Kastner DL
Blood; 2008 Sep; 112(5):1794-803. PubMed ID: 18577712
[TBL] [Abstract][Full Text] [Related]
3. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.
Chae JJ; Wood G; Masters SL; Richard K; Park G; Smith BJ; Kastner DL
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9982-7. PubMed ID: 16785446
[TBL] [Abstract][Full Text] [Related]
4. [The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases].
Dzhidoian Z
Georgian Med News; 2011 May; (194):53-6. PubMed ID: 21685523
[TBL] [Abstract][Full Text] [Related]
5. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.
Sugiyama R; Agematsu K; Migita K; Nakayama J; Mokuda S; Ogura F; Haraikawa K; Okumura C; Suehiro S; Morikawa S; Ito Y; Masumoto J
Mol Biol Rep; 2014 Jan; 41(1):545-53. PubMed ID: 24318677
[TBL] [Abstract][Full Text] [Related]
6. Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'.
Fragouli E; Eliopoulos E; Petraki E; Sidiropoulos P; Aksentijevich I; Galanakis E; Kritikos H; Repa A; Fragiadakis G; Boumpas D; Goulielmos GN
Clin Genet; 2008 Feb; 73(2):152-9. PubMed ID: 18177465
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever.
Weinert C; Grütter C; Roschitzki-Voser H; Mittl PR; Grütter MG
J Mol Biol; 2009 Nov; 394(2):226-36. PubMed ID: 19729025
[TBL] [Abstract][Full Text] [Related]
8. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.
Papin S; Cuenin S; Agostini L; Martinon F; Werner S; Beer HD; Grütter C; Grütter M; Tschopp J
Cell Death Differ; 2007 Aug; 14(8):1457-66. PubMed ID: 17431422
[TBL] [Abstract][Full Text] [Related]
9. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype.
Omenetti A; Carta S; Delfino L; Martini A; Gattorno M; Rubartelli A
Ann Rheum Dis; 2014 Feb; 73(2):462-9. PubMed ID: 23505242
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever.
Repa A; Bertsias GK; Petraki E; Choulaki C; Vassou D; Kambas K; Boumpas DT; Goulielmos G; Sidiropoulos P
Hum Immunol; 2015 Jul; 76(7):488-95. PubMed ID: 26074413
[TBL] [Abstract][Full Text] [Related]
11. Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1β levels.
Hesker PR; Nguyen M; Kovarova M; Ting JP; Koller BH
PLoS One; 2012; 7(11):e51105. PubMed ID: 23226472
[TBL] [Abstract][Full Text] [Related]
12. Pyrin, product of the MEFV locus, interacts with the proapoptotic protein, Siva.
Balci-Peynircioglu B; Waite AL; Hu C; Richards N; Staubach-Grosse A; Yilmaz E; Gumucio DL
J Cell Physiol; 2008 Sep; 216(3):595-602. PubMed ID: 18330885
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis.
Chae JJ; Komarow HD; Cheng J; Wood G; Raben N; Liu PP; Kastner DL
Mol Cell; 2003 Mar; 11(3):591-604. PubMed ID: 12667444
[TBL] [Abstract][Full Text] [Related]
14. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants.
Yu JW; Fernandes-Alnemri T; Datta P; Wu J; Juliana C; Solorzano L; McCormick M; Zhang Z; Alnemri ES
Mol Cell; 2007 Oct; 28(2):214-27. PubMed ID: 17964261
[TBL] [Abstract][Full Text] [Related]
15. Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps.
Skendros P; Chrysanthopoulou A; Rousset F; Kambas K; Arampatzioglou A; Mitsios A; Bocly V; Konstantinidis T; Pellet P; Angelidou I; Apostolidou E; Ritis D; Tsironidou V; Galtsidis S; Papagoras C; Stakos D; Kouklakis G; Dalla V; Koffa M; Mitroulis I; Theodorou I; Ritis K
J Allergy Clin Immunol; 2017 Nov; 140(5):1378-1387.e13. PubMed ID: 28342915
[TBL] [Abstract][Full Text] [Related]
16. The regulation of MEFV expression and its role in health and familial Mediterranean fever.
Grandemange S; Aksentijevich I; Jeru I; Gul A; Touitou I
Genes Immun; 2011 Oct; 12(7):497-503. PubMed ID: 21776013
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns.
Nalbantoglu S; Tanyolac B; Berdeli A
Scand J Rheumatol; 2013; 42(2):159-62. PubMed ID: 22934972
[TBL] [Abstract][Full Text] [Related]
18. A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever.
Moghaddas F; Llamas R; De Nardo D; Martinez-Banaclocha H; Martinez-Garcia JJ; Mesa-Del-Castillo P; Baker PJ; Gargallo V; Mensa-Vilaro A; Canna S; Wicks IP; Pelegrin P; Arostegui JI; Masters SL
Ann Rheum Dis; 2017 Dec; 76(12):2085-2094. PubMed ID: 28835462
[TBL] [Abstract][Full Text] [Related]
19. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
[TBL] [Abstract][Full Text] [Related]
20. The PRY/SPRY domain of pyrin/TRIM20 interacts with β
Samukawa S; Yoshimi R; Kirino Y; Nakajima H
Sci Rep; 2021 Dec; 11(1):23613. PubMed ID: 34880353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
